4/A

FORM 4/A SUBMISSION

Company: PMV Pharmaceuticals, Inc.
Filed: October 2, 2020
Period of Report: September 25, 2020
Accession Number: 0001209191-20-053342

View Document ↗ View on SEC.gov ↗